The only legal access is through clinical trials or, in extreme cases, expanded access
In the United States, the Centers for Disease Control and Prevention (CDC) reports that over 38.4 million individuals, approximately 11.6% of the population, are currently living with diabetes [2]
You lie on a table while a scanning arm passes over you
protect from light and moisture Contraindications & Handling Warnings For licensed research institutions and professionals only Do not inject or consume under any circumstances Avoid contact with skin, eyes, or mucous membranes Use appropriate PPE (personal protective equipment) when handling Dispose of unused material in compliance with local regulations Quality Assurance Produced in a cGMP-compliant facility in the USA Subjected to independent laboratory testing for identity, potency, and purity Certificate of Analysis (CoA) available upon request for research verification FDA Disclaimer This product is not approved by the United States Food and Drug Administration (FDA)
Even moderate walking, 7,000 to 10,000 steps daily, meaningfully improves outcomes
Published studies have investigated: Researchers are particularly interested in how combining GLP-1, GIP, and glucagon receptor activity may influence broader metabolic systems compared with single-pathway compounds
